Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9

[1]  David J Weber,et al.  S100 proteins in cancer , 2015, Nature Reviews Cancer.

[2]  B. Aronow,et al.  p62 is required for stem cell/progenitor retention through inhibition of IKK/NF-κB/Ccl4 signaling at the bone marrow macrophage-osteoblast niche. , 2014, Cell reports.

[3]  Shuo Lin,et al.  TNF-mediated inflammation represses GATA1 and activates p38 MAP kinase in RPS19-deficient hematopoietic progenitors. , 2014, Blood.

[4]  D. Ruggero,et al.  Marrow failure: a window into ribosome biology. , 2014, Blood.

[5]  B. Ebert,et al.  Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS. , 2014, Cancer cell.

[6]  T. Roberts,et al.  Hematopoiesis and RAS-driven myeloid leukemia differentially require PI3K isoform p110α. , 2014, The Journal of clinical investigation.

[7]  Jeffrey A. Magee,et al.  Haematopoietic stem cells require a highly regulated protein synthesis rate , 2014, Nature.

[8]  B. Ebert,et al.  The emerging importance of ribosomal dysfunction in the pathogenesis of hematologic disorders , 2014, Leukemia & lymphoma.

[9]  B. Ebert,et al.  Deletion 5q MDS: molecular and therapeutic implications. , 2013, Best practice & research. Clinical haematology.

[10]  Sheng Wei,et al.  Induction of myelodysplasia by myeloid-derived suppressor cells. , 2013, The Journal of clinical investigation.

[11]  E. Hsiao,et al.  Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche. , 2013, Cell stem cell.

[12]  W. Du,et al.  Inflammation-Mediated Notch Signaling Skews Fanconi Anemia Hematopoietic Stem Cell Differentiation , 2013, The Journal of Immunology.

[13]  Lesley A. Mathews,et al.  Targeting IRAK1 as a therapeutic approach for myelodysplastic syndrome. , 2013, Cancer cell.

[14]  Steven A Carr,et al.  Integrated proteomic analysis of post-translational modifications by serial enrichment , 2013, Nature Methods.

[15]  C. Verschoor,et al.  Blood CD33(+)HLA-DR(−) myeloid-derived suppressor cells are increased with age and a history of cancer , 2013, Journal of leukocyte biology.

[16]  D. Neuberg,et al.  Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells , 2013, Leukemia.

[17]  Qi Zhang,et al.  Ribosomal protein S14 unties the MDM2–p53 loop upon ribosomal stress , 2013, Oncogene.

[18]  G. Jansen,et al.  Cytotoxic effects of bortezomib in myelodysplastic syndrome/acute myeloid leukemia depend on autophagy-mediated lysosomal degradation of TRAF6 and repression of PSMA1. , 2012, Blood.

[19]  M. Manz,et al.  Demand-adapted regulation of early hematopoiesis in infection and inflammation. , 2012, Blood.

[20]  John M. Ashton,et al.  Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia. , 2011, Blood.

[21]  Debashis Sahoo,et al.  Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age , 2011, Proceedings of the National Academy of Sciences.

[22]  J. Radich,et al.  IL-6 controls leukemic multipotent progenitor cell fate and contributes to chronic myelogenous leukemia development. , 2011, Cancer cell.

[23]  S. Lam,et al.  TRAF6 is an amplified oncogene bridging the RAS and NF-κB pathways in human lung cancer. , 2011, The Journal of clinical investigation.

[24]  K. Karbstein.  Inside the 40S ribosome assembly machinery. , 2011, Current opinion in chemical biology.

[25]  B. Ebert.  Molecular dissection of the 5q deletion in myelodysplastic syndrome. , 2011, Seminars in oncology.

[26]  I. Weissman,et al.  Reduced ribosomal protein gene dosage and p53 activation in low-risk myelodysplastic syndrome. , 2011, Blood.

[27]  Cherisse R. Loucks,et al.  Ribosome Assembly Factors Prevent Premature Translation Initiation by 40S Assembly Intermediates , 2011, Science.

[28]  M. Björkholm,et al.  Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  J. Kutok,et al.  Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells. , 2011, Blood.

[30]  L. Chin,et al.  Telomere dysfunction induces metabolic and mitochondrial compromise , 2011, Nature.

[31]  S. Pileri,et al.  Induction of p53 and up-regulation of the p53 pathway in the human 5q- syndrome. , 2010, Blood.

[32]  Charles P. Lin,et al.  Bone progenitor dysfunction induces myelodysplasia and secondary leukemia , 2010, Nature.

[33]  A. Karsan,et al.  Deregulation of innate immune signaling in myelodysplastic syndromes is associated with deletion of chromosome arm 5q , 2010, Cell cycle.

[34]  A. Warren,et al.  A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q− syndrome , 2009, Nature Medicine.

[35]  Ryan D. Morin,et al.  Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype , 2010, Nature Medicine.

[36]  B. Strunk,et al.  Powering through ribosome assembly. , 2009, RNA.

[37]  D. Foell,et al.  The endogenous Toll–like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer , 2009, Journal of leukocyte biology.

[38]  Zhihua Liu,et al.  A novel p53 target gene, S100A9, induces p53-dependent cellular apoptosis and mediates the p53 apoptosis pathway. , 2009, The Biochemical journal.

[39]  B. Ebert.  Deletion 5q in myelodysplastic syndrome: a paradigm for the study of hemizygous deletions in cancer , 2009, Leukemia.

[40]  G. Mufti,et al.  IL‐17‐producing CD4+ T cells, pro‐inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome , 2009, British journal of haematology.

[41]  Christopher Y. Park,et al.  Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects , 2008, Nature Genetics.

[42]  T. Golub,et al.  Identification of RPS14 as a 5q- syndrome gene by RNA interference screen , 2007, Nature.

[43]  K. Dietz,et al.  Telomere length analysis in monocytes and lymphocytes from patients with systemic lupus erythematosus using multi-color flow-FISH , 2007, Lupus.

[44]  W. Nacken,et al.  Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock , 2007, Nature Medicine.

[45]  Irving L. Weissman,et al.  Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age , 2007, Nature.

[46]  H. Lodish,et al.  In vitro erythropoiesis from bone marrow-derived progenitors provides a physiological assay for toxic and mutagenic compounds , 2007, Proceedings of the National Academy of Sciences.

[47]  M. Mann,et al.  Analysis of the topology of protein complexes using cross-linking and mass spectrometry. , 2007, Cold Spring Harbor Protocols.

[48]  Jacqueline Noaillac-Depeyre,et al.  Impaired ribosome biogenesis in Diamond-Blackfan anemia. , 2007, Blood.

[49]  Hiroyuki Aburatani,et al.  Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis , 2006, Nature Cell Biology.

[50]  S. Karlsson,et al.  Erythropoiesis in the Rps19 disrupted mouse: Analysis of erythropoietin response and biochemical markers for Diamond-Blackfan anemia. , 2006, Blood cells, molecules & diseases.

[51]  C. Heizmann,et al.  The Calcium-binding Protein S100A2 Interacts with p53 and Modulates Its Transcriptional Activity* , 2005, Journal of Biological Chemistry.

[52]  K. Dietz,et al.  Accelerated telomere shortening in glycosylphosphatidylinositol (GPI)-negative compared with GPI-positive granulocytes from patients with paroxysmal nocturnal hemoglobinuria (PNH) detected by proaerolysin flow-FISH. , 2005, Blood.

[53]  K. Hirokawa,et al.  Expression of TNF receptors and related signaling molecules in the bone marrow from patients with myelodysplastic syndromes. , 2003, Leukemia research.

[54]  P. Dent,et al.  Tumor necrosis factor-alpha expressed constitutively in erythroid cells or induced by erythropoietin has negative and stimulatory roles in normal erythropoiesis and erythroleukemia. , 2003, Blood.

[55]  L. Terracciano,et al.  Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6. , 2000, Science.

[56]  C. Heizmann,et al.  Transcriptional activation of the human S100A2 promoter by wild‐type p53 , 1999, FEBS letters.

[57]  K. Matsushima,et al.  Inhibition of immature erythroid progenitor cell proliferation by macrophage inflammatory protein-1alpha by interacting mainly with a C-C chemokine receptor, CCR1. , 1997, Blood.

[58]  I. Weissman,et al.  The aging of hematopoietic stem cells , 1996, Nature Medicine.

[59]  R. Means.  Pathogenesis of the anemia of chronic disease: A cytokine‐mediated anemia , 1995, Stem cells.

[60]  L. Lajtha,et al.  A kinetic model of the erythron. , 1961, Proceedings of the Royal Society of Medicine.